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Next-generation sequencing has shown that the majority of the human genome does not
encode proteins, yet many such “non-coding” regions are actively transcribed into RNA. In
particular, long non-coding RNAs (lncRNAs) have received considerable interest for their
essential roles in numerous biological processes. Defined as non-protein-coding transcripts longer
than 200 nucleotides, lncRNAs are frequently expressed in a tissue-specific or developmental
stage-specific manner (1, 2). Multiple studies have shown lncRNAs to be dysregulated in disease,
and genome-wide association studies (GWAS) have also identified numerous single nucleotide
polymorphisms (SNPs) within lncRNAs (3–5). These features distinguish them as attractive
candidates for therapeutic targets or biomarkers. While still in its infancy, the dissection of lncRNA
biology has unveiled critical roles in immune cell development and function. However, as the
functions of most lncRNAs are yet to be determined, the field must fill a considerable void to
understand the breadth of their roles in immunity. This Research Topic focuses on how lncRNAs
contribute to immune function in a variety of different contexts, and what key questions drive this
rapidly expanding field.

DOSAGE COMPENSATION AND X-LINKED IMMUNE GENES
Females have a more responsive immune system than males (6, 7), potentially driving a higher
predisposition to autoimmune diseases such as systemic lupus erythematosus (SLE) (8). The X
chromosome carries a significant number of immune-related genes, but how this translates to sex
disparities in immune diseases remains to be determined. Xist is one of the best characterized
lncRNAs, and functions as an effector of dosage compensation in female cells. Xist maintains
inactivation of one X chromosome by binding along its length and recruiting repressive factors to
silence transcription. Immune cells, however, regulate X chromosome inactivation through diverse
mechanisms that are not limited to the use of Xist RNA, as recently revealed by Syrett et al. For
instance, the inactivated X in female murine plasmacytoid dendritic cells (pDCs) lacks both Xist
RNA and the repressive chromatin modification H3K27me3. Interestingly, pDCs from female
mice that spontaneously develop SLE-like disease show increased biallelic expression of the Xlinked gene Tlr7, as compared to healthy female mice. Further delineating the mechanisms of
X chromosome inactivation in immune cells will be necessary before we can develop a complete
understanding of how sex and sex-linked genes contribute to autoimmune diseases.
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LNCRNAS IN RICKETTSIAL INFECTION

addition, while SNPs in lncRNAs likely affect their secondary and
tertiary structure, we cannot currently predict how this will alter
their function. Castellanos-Rubio and Ghosh review the diseaseassociated lncRNA SNPs that have been described thus far.
Further inquiry and development of tools to interpret lncRNA
structure and function will be necessary before the impact of
lncRNA SNPs (and other genetic variants) on disease can be
fully realized.

The Rickettsia genus of Gram-negative obligate intracellular
bacteria is transmitted to humans via arthropod vectors,
including ticks, fleas, and lice, and can infect the vascular
endothelium to cause illnesses such as Rocky Mountain spotted
fever. There are increasing concerns over the prevalence
of Rickettsia due to climate change and the spread of
vector populations. Understanding rickettsial infection and
developing novel therapeutics to mitigate its spread through the
vascular endothelium will thus be crucial in the near future.
Chowdhury et al. have begun to address the roles of lncRNAs in
the host response to Rickettsia species using a mouse model of R.
conorii infection. The authors identified two enhancer lncRNAs
affecting expression of nearby genes, Id2 and Apol10b, which have
not been previously studied in rickettsial infection. Furthermore,
these two lncRNAs exhibit differential expression in infected
macrophages compared to endothelial cells, emphasizing the cell
type-specificity of lncRNAs. The resulting genome-wide analysis
of lncRNA expression during rickettsial infection establishes
a foundation to further study the host immune response to
Rickettsia species and reveals cell type-specific signaling pathways
mediated by enhancer lncRNAs.

CIRCULAR RNAS AS A NEW CLASS OF
IMMUNE REGULATORS
While lncRNAs typically display features associated with linear
messenger RNA, such as 5′ capping, alternative splicing, and
polyadenylation, non-coding RNA loci can also be transcribed
to form circular RNA (circRNAs). These circRNAs form closed
loops without 5′ capping or polyadenylation and can contain
multiple exons. Similar to lncRNAs, circRNAs are frequently
expressed in a tissue-specific manner, undergo chemical
modifications, and function through varied mechanisms.
Yang et al. review the mechanisms of circRNA biogenesis,
summarize the current understanding of their function in
immunity, and present approaches and limitations to studying
circRNA function.

VIRAL AND HOST LNCRNAS IN ANTIVIRAL
IMMUNITY

CONCLUSION

Some of the most interesting advancements in our understanding
of lncRNAs in immunity come from the study of their roles
in viral infection. While it would be intuitive to assume host
lncRNAs exist to suppress viral infections, it has been shown
that host lncRNAs can actually increase viral replication and
pathogenesis during certain infections (9). This begets the need
to further examine what purpose both host and viral lncRNAs
serve, and how it may change in the context of non-infected
and infected states. Wang reviews in detail the known lncRNAs
involved in multiple steps of the viral life cycle and infection.

lncRNAs are now an established class of functional molecules
with physiological relevance shown in nearly every human
organ system. Their roles in immunity have been identified
in immune cell differentiation, maintenance, and effector
function. Given that only a fraction of lncRNAs have been
functionally characterized a significant wealth of insight
awaits discovery. Moreover, as personalized medicine
begins to drive the use of genetic tools in the clinic, we
can expect the identification of clinically-relevant lncRNA
variants and the development of therapeutics that target
lncRNA function.

LNCING GWAS SNPS TO DISEASE
PATHOGENESIS
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GWAS have provided a more complete understanding of
complex diseases. Of the more than 70,000 variant-trait
associations cataloged from GWAS (10), a majority of these
map to non-coding regions of the genome, including those
containing lncRNAs. Despite this, the impact of only a few SNPs
on lncRNA function has been described. A major limitation in
the field is that the function of most lncRNAs is unknown. In
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